Aortic stenosis cost-effectiveness of therapy

Revision as of 17:23, 2 January 2015 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search


Resident
Survival
Guide

Aortic Stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Cardiac Stress Test

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Aortic Valve Area

Aortic Valve Area Calculation

Treatment

General Approach

Medical Therapy

Surgery

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Transcatheter Aortic Valve Replacement (TAVR)

TAVR vs SAVR
Critical Pathway
Patient Selection
Imaging
Evaluation
Valve Types
TAVR Procedure
Post TAVR management
AHA/ACC Guideline Recommendations

Follow Up

Prevention

Precautions and Prophylaxis

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic stenosis cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic stenosis cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic stenosis cost-effectiveness of therapy

CDC on Aortic stenosis cost-effectiveness of therapy

Aortic stenosis cost-effectiveness of therapy in the news

Blogs on Aortic stenosis cost-effectiveness of therapy

Directions to Hospitals Treating Aortic stenosis cost-effectiveness of therapy

Risk calculators and risk factors for Aortic stenosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Transcatheter aortic valve implantation (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.[1]

References

  1. Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A; et al. (2013). "Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation". Health Technol Assess. 17 (33): 1–86. doi:10.3310/hta17330. PMID 23948359.


Template:WH Template:WS